This is the list of the largest public listed companies in the Biotechnology industry from the United States by market capitalization with links to their reference stock.
Company Profile:
Amarantus Bioscience Holdings, Inc.
Market Cap (USD):
$3.2 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Windtree Therapeutics, Inc.
Market Cap (USD):
$3.2 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
BioCube, Inc.
Market Cap (USD):
$3.1 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Qrons, Inc.
Market Cap (USD):
$3.1 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Evolutionary Genomics, Inc.
Market Cap (USD):
$3.0 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Petros Pharmaceuticals, Inc.
Market Cap (USD):
$3.0 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Aridis Pharmaceuticals, Inc.
Market Cap (USD):
$3.0 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Innovation Pharmaceuticals, Inc.
Market Cap (USD):
$2.9 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Advaxis, Inc.
Market Cap (USD):
$2.9 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Codiak BioSciences, Inc.
Market Cap (USD):
$2.8 M
(June 1, 2023)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
NeuBase Therapeutics, Inc.
Market Cap (USD):
$2.8 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Qualigen Therapeutics, Inc.
Market Cap (USD):
$2.7 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Zosano Pharma Corporation
Market Cap (USD):
$2.7 M
(Dec. 1, 2022)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Endonovo Therapeutics, Inc.
Market Cap (USD):
$2.7 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Affymax, Inc.
Market Cap (USD):
$2.6 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
iBio, Inc.
Market Cap (USD):
$2.6 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Cyclacel Pharmaceuticals, Inc.
Market Cap (USD):
$2.5 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Scopus BioPharma Inc.
Market Cap (USD):
$2.5 M
(Jan. 1, 2023)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Regen Biopharma, Inc.
Market Cap (USD):
$2.5 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Salarius Pharmaceuticals, Inc.
Market Cap (USD):
$2.5 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Avenue Therapeutics, Inc.
Market Cap (USD):
$2.5 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
EyeGate Pharmaceuticals, Inc.
Market Cap (USD):
$2.5 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
InVivo Therapeutics Holdings Corp.
Market Cap (USD):
$2.4 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
ADiTx Therapeutics, Inc.
Market Cap (USD):
$2.2 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
GB Sciences, Inc.
Market Cap (USD):
$2.2 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
CohBar, Inc.
Market Cap (USD):
$2.2 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Immune Pharmaceuticals, Inc.
Market Cap (USD):
$2.1 M
(Aug. 1, 2022)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Adial Pharmaceuticals, Inc.
Market Cap (USD):
$2.1 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Calithera Biosciences, Inc.
Market Cap (USD):
$2.0 M
(Jan. 1, 2023)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
GlobeImmune, Inc.
Market Cap (USD):
$2.0 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology